TITLE

For Every Health Policy Action, There Can Be Reciprocal Overreaction

AUTHOR(S)
Kissick, William L.
PUB. DATE
June 2003
SOURCE
Frontiers of Health Services Management;Summer2003, Vol. 19 Issue 4, p35
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on the importance of patient participation for improving healthcare delivery. Factors involved in providing care to those who need it; Strategies for changing the health care culture; Convergences of patients' equal access, high quality and cost containment in health care.
ACCESSION #
10515646

 

Related Articles

  • The price of noncompliance.  // Family Practice Management;Feb2002, Vol. 9 Issue 2, p23 

    Reports the influence of increased pharmaceutical costs and co-payments in drug noncompliance in the United States.

  • Adherence is a pricey problem. M. A. // Medical Marketing & Media;Jun2010, Vol. 45 Issue 6, p11 

    The article reports on the claims of an Express Scripts study that the medical costs of patient non-adherence to therapy costs 106 billion dollar each year in the U.S.

  • Noncompliance costs billions: Researcher.  // CMAJ: Canadian Medical Association Journal;05/15/97, Vol. 156 Issue 10, p1371 

    Reports on research by Robert Coambs of the University of Toronto's Centre for Health Promotion which evaluated the economic cost of patient noncompliance in Canada. Inappropriate prescribing as another concern in the utilization of prescription medicines; Inclusion of components to enhance...

  • Packaging plays bigger role in drive to boost Rx compliance.  // Chain Drug Review;4/8/2013, Vol. 35 Issue 6, p29 

    The article offers the author's insights regarding the importance of packaging in the improvement of adherence rates and reduction of overall health care costs.

  • Cost a major reason for medication nonadherence.  // PharmacoEconomics & Outcomes News;10/13/2012, Issue 664, p6 

    The article reveals that cost is still a major reason for patient nonadherence to drug therapy, based on the results of an online survey of over 2,400 companies conducted by CVS Caremark.

  • Costs prevent 10% of Canadians from adhering to therapy.  // PharmacoEconomics & Outcomes News;2/4/2012, Issue 646, p3 

    The article reports that approximately ten percent of Canadians do not comply to drug therapy because of costs, according to the findings of a survey published in the January 16, 2012 issue of the "Canadian Medical Association Journal."

  • Medication Costs, Adherence, And Health Outcomes Among Medicare Beneficiaries. Mojtabai, Ramin; Olfson, Mark // Health Affairs;Jul/Aug2003, Vol. 22 Issue 4, p220 

    In a two-year period more than two million elderly Medicare beneficiaries did not adhere to drug treatment regimens because of cost. This poor adherence tended to be more common among beneficiaries with no or partial medication coverage and was associated with poorer health and higher rates of...

  • Cost sharing can discourage adherence in chronically ill. Walker, Tracey // Managed Healthcare Executive;Aug2007, Vol. 17 Issue 8, p10 

    The article reports on the impact of increased cost sharing and the lower rates of drug treatment to the chronically ill patients in the U.S. Researchers from Research and Development (RAND) Health's Bing Center on Health Economics analyzed cost-sharing features of prescription drug plan cost...

  • Drug costs may hamper patient health.  // Geriatrics;Oct2004, Vol. 59 Issue 10, p16 

    Reports on the results of surveys on the impact of drug costs on patient health and compliance in the United States. Estimated prevalence of hypertension among adults by age and sex; Decline in self-reported health status for cardiovascular disease; Need for physicians to ask patients whether...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics